254 related articles for article (PubMed ID: 36385600)
21. Association Between Medications and Herpes Zoster in Japanese Patients with Rheumatoid Arthritis: A 5-year Prospective Cohort Study.
Harada S; Sakai R; Hirano F; Miyasaka N; Harigai M;
J Rheumatol; 2017 Jul; 44(7):988-995. PubMed ID: 28412701
[TBL] [Abstract][Full Text] [Related]
22. Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register.
Redeker I; Albrecht K; Kekow J; Burmester GR; Braun J; Schäfer M; Zink A; Strangfeld A
Ann Rheum Dis; 2022 Jan; 81(1):41-47. PubMed ID: 34321218
[TBL] [Abstract][Full Text] [Related]
23. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Gianfrancesco M; Hyrich KL; Al-Adely S; Carmona L; Danila MI; Gossec L; Izadi Z; Jacobsohn L; Katz P; Lawson-Tovey S; Mateus EF; Rush S; Schmajuk G; Simard J; Strangfeld A; Trupin L; Wysham KD; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Wallace ZS; Yazdany J; Machado PM; Robinson PC;
Ann Rheum Dis; 2020 Jul; 79(7):859-866. PubMed ID: 32471903
[TBL] [Abstract][Full Text] [Related]
24. Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster.
Winthrop KL; Baddley JW; Chen L; Liu L; Grijalva CG; Delzell E; Beukelman T; Patkar NM; Xie F; Saag KG; Herrinton LJ; Solomon DH; Lewis JD; Curtis JR
JAMA; 2013 Mar; 309(9):887-95. PubMed ID: 23462785
[TBL] [Abstract][Full Text] [Related]
25. Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy.
Opastirakul S; Chartapisak W
Pediatr Nephrol; 2005 Dec; 20(12):1750-5. PubMed ID: 16133037
[TBL] [Abstract][Full Text] [Related]
26. Herpes zoster infection in childhood-onset systemic lupus erythematosus patients: a large multicenter study.
Ferreira JC; Marques HH; Ferriani MP; Gormezano NW; Terreri MT; Pereira RM; Magalhães CS; Campos LM; Bugni V; Okuda EM; Marini R; Pileggi GS; Barbosa CM; Bonfá E; Silva CA
Lupus; 2016 Jun; 25(7):754-9. PubMed ID: 26821966
[TBL] [Abstract][Full Text] [Related]
27. Herpes zoster vaccination in SLE: a pilot study of immunogenicity.
Guthridge JM; Cogman A; Merrill JT; Macwana S; Bean KM; Powe T; Roberts V; James JA; Chakravarty EF
J Rheumatol; 2013 Nov; 40(11):1875-80. PubMed ID: 24037550
[TBL] [Abstract][Full Text] [Related]
28. Association of herpes zoster infection with clinical characteristics and MBL2 gene polymorphisms in Chinese children with systemic lupus erythematosus.
Wu SA; Yeh KW; Yao TC; Huang JL
Pediatr Infect Dis J; 2011 Aug; 30(8):656-60. PubMed ID: 21343839
[TBL] [Abstract][Full Text] [Related]
29. Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders.
Wolfe F; Michaud K; Chakravarty EF
Rheumatology (Oxford); 2006 Nov; 45(11):1370-5. PubMed ID: 17003175
[TBL] [Abstract][Full Text] [Related]
30. Significant Associations of Neurological Complications of Herpes Zoster With Stroke in Rheumatoid Arthritis Patients.
Liao TL; Lin CH; Chen HH; Chen YM; Lin CC; Chen DY
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724649
[TBL] [Abstract][Full Text] [Related]
31. Risk of herpes/herpes zoster during anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Systematic review and meta-analysis.
Che H; Lukas C; Morel J; Combe B
Joint Bone Spine; 2014 May; 81(3):215-21. PubMed ID: 23932722
[TBL] [Abstract][Full Text] [Related]
32. Lymphopaenia, anti-Ro/anti-RNP autoantibodies, renal involvement and cyclophosphamide use correlate with increased risk of herpes zoster in patients with systemic lupus erythematosus.
Hu SC; Lin CL; Lu YW; Chen GS; Yu HS; Wu CS; Lan CC
Acta Derm Venereol; 2013 May; 93(3):314-8. PubMed ID: 22983107
[TBL] [Abstract][Full Text] [Related]
33. Risk of herpes zoster in patients with rheumatoid arthritis in the biologics era from 2011 to 2015 and its association with methotrexate, biologics, and corticosteroids.
Yamaguchi R; Tanaka E; Nakajima A; Inoue E; Abe M; Sugano E; Sugitani N; Saka K; Ochiai M; Higuchi Y; Sugimoto N; Ikari K; Yamanaka H; Harigai M
Mod Rheumatol; 2022 Apr; 32(3):522-527. PubMed ID: 34897494
[TBL] [Abstract][Full Text] [Related]
34. Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis.
Garnier C; Ribes D; Chauveau D; Huart A; Pugnet G; Adoue D; Prevot G; Alric L; Delobel P; Derumeaux H; Mengelle C; Sailler L; Moulis G
J Rheumatol; 2018 Nov; 45(11):1541-1548. PubMed ID: 30008461
[TBL] [Abstract][Full Text] [Related]
35. Herpes zoster in SLE: prevalence, incidence and risk factors.
Kwan A; Rayes HA; Lazova T; Anderson N; Bonilla D; Su J; Touma Z
Lupus Sci Med; 2022 Jan; 9(1):. PubMed ID: 35017186
[TBL] [Abstract][Full Text] [Related]
36. Herpes zoster vaccination in systemic lupus erythematosus: the current status.
Mok CC
Hum Vaccin Immunother; 2019; 15(1):45-48. PubMed ID: 30130445
[TBL] [Abstract][Full Text] [Related]
37. Incident and recurrent herpes zoster for first-line bDMARD and tsDMARD users in seropositive rheumatoid arthritis patients: a nationwide cohort study.
Jeong S; Choi S; Park SM; Kim J; Ghang B; Lee EY
Arthritis Res Ther; 2022 Jul; 24(1):180. PubMed ID: 35902964
[TBL] [Abstract][Full Text] [Related]
38. [Herpes zoster in connective tissue diseases: II. Rheumatoid arthritis and mixed connective tissue disease in comparison with systemic lupus erythematosus].
Yamauchi Y; Nagasawa K; Tada Y; Tsukamoto H; Yoshizawa S; Mayumi T; Niho Y; Kusaba T
Kansenshogaku Zasshi; 1991 Nov; 65(11):1389-93. PubMed ID: 1791339
[TBL] [Abstract][Full Text] [Related]
39. No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database.
Sakai R; Kasai S; Hirano F; Harada S; Kihara M; Yokoyama W; Tsutsumino M; Nagasaka K; Koike R; Yamanaka H; Miyasaka N; Harigai M
Int J Rheum Dis; 2018 Sep; 21(9):1670-1677. PubMed ID: 29667330
[TBL] [Abstract][Full Text] [Related]
40. Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome.
Kahl LE
J Rheumatol; 1994 Jan; 21(1):84-6. PubMed ID: 8151595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
